KAVI-Institute of Clinical Research Wins IAVI EQA Awards

KAVI-Institute of Clinical Research (KAVI-ICR) was awarded the 2022 International AIDS Vaccine Initiative (IAVI) External Quality Assessment (EQA) Awards For Tier 1 and Tier 2. This is the second year running that the Institute has won this prestigious award. It recognises the best-performing laboratories amongst their Clinical Research Centres in Africa. The Institute at the University of Nairobi, Faculty of Health Sciences, KNH Campus was first among Tier 1 and the Kangemi site among Tier 2.

IAVI was represented by Mr. Bashir Farah and Ms. Nancy Kisangau, who presented the awards to the KAVI-ICR laboratory manager Irene Ann Mwangi. Also present at the awards ceremony were KAVI-ICR staff such as, IT & Data Manager Moses Mundia, Medical Manager Dr Michael Mutua, Head of Finance Nancy Thairu, Head of Administration Bernard Omondi, Senior Scientist Professor Omu Anzala and KAVI-ICR Director Prof. Walter Jaoko.

Discussing the Institute winning the awards two years running Prof. Jaoko said, “Achieving the EQA Awards two years running highlights our continuous rise in clinical research of the highest standards. Our Institute’s vision is to be of excellence in health research, innovation and knowledge translation and through our work we strive to have a direct impact on healthcare with the region.”